UK fertility clinic staff are exploiting a loophole in UK law to help couples choose the healthiest and smartest embryos during IVF treatment. The practice involves sending raw genetic data for their embryos abroad, where it is analyzed using complex algorithms that predict IQ, height, and health risks.
Critics argue that this technique is unproven and unethical, but its proponents claim it can provide an edge in choosing the best embryo. One US company, Herasight, charges Β£37,000 to analyze an unlimited number of embryos, a fee that some couples feel is worth paying for a chance at having healthier and more intelligent children.
The loophole in question lies in UK data protection laws, which allow patients to access their own genetic data and send it abroad for analysis. While the Human Fertilisation and Embryology Authority (HFEA) has stated that this practice is unlawful within the UK, some fertility clinics are taking a more permissive approach.
Dr Cristina Hickman, a senior embryologist at Avenues fertility clinic in London, warns that this can lead to "legal and ethical confusion." She argues that while she would not block a couple's request to choose a particular embryo if it did not conflict with medical safety, the HFEA should be allowed to regulate the use of polygenic testing within clinics.
The European Society of Genetics has condemned this technique as "unproven and unethical," citing broader concerns about creating a stratified society where wealthier parents can select embryos based on their perceived genetic superiority. Clinical geneticist Angus Clarke notes that some parents may be tempted by the promise of selecting the "best child possible" β but warns that it might be difficult to live up to those expectations.
As for Herasight, the company claims that its algorithms are backed by scientific research and has worked with UK-based couples who have undergone IVF treatment. However, critics argue that this technique is still murky science being applied in an emotionally charged context.
Critics argue that this technique is unproven and unethical, but its proponents claim it can provide an edge in choosing the best embryo. One US company, Herasight, charges Β£37,000 to analyze an unlimited number of embryos, a fee that some couples feel is worth paying for a chance at having healthier and more intelligent children.
The loophole in question lies in UK data protection laws, which allow patients to access their own genetic data and send it abroad for analysis. While the Human Fertilisation and Embryology Authority (HFEA) has stated that this practice is unlawful within the UK, some fertility clinics are taking a more permissive approach.
Dr Cristina Hickman, a senior embryologist at Avenues fertility clinic in London, warns that this can lead to "legal and ethical confusion." She argues that while she would not block a couple's request to choose a particular embryo if it did not conflict with medical safety, the HFEA should be allowed to regulate the use of polygenic testing within clinics.
The European Society of Genetics has condemned this technique as "unproven and unethical," citing broader concerns about creating a stratified society where wealthier parents can select embryos based on their perceived genetic superiority. Clinical geneticist Angus Clarke notes that some parents may be tempted by the promise of selecting the "best child possible" β but warns that it might be difficult to live up to those expectations.
As for Herasight, the company claims that its algorithms are backed by scientific research and has worked with UK-based couples who have undergone IVF treatment. However, critics argue that this technique is still murky science being applied in an emotionally charged context.